Biblio Discovery — Demo Discovery Service

3 hasil untuk "Paul J. Adam"

Menampilkan 1–3 · 0,35 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid Tumors

    Vladimir Voynov; Paul J. Adam; Andrew E. Nixon dkk.

    Antibodies, Vol. 9 No. 4 · 2020 · Inggris · DOAJ Scopus

    T-cell Engaging bispecific antibodies (TcEs) that can re-direct cytotoxic T-cells to kill cancer cells have been validated in clinical studies. To date, the clinical success with these agents has mainly been seen in hematologic tumor indications. However, an increasing number of TcEs are currently…

  2. Artikel Jurnal

    LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager

    Leticia Corrales; Susanne Hipp; Katharina Martin dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    Colorectal cancer (CRC) is one of the most common cancers worldwide and demands more effective treatments. We sought to identify tumor selective CRC antigens and their therapeutic potential for cytotoxic T-cell targeting by transcriptomic and immunohistochemical analysis. LY6G6D was identified as a…

  3. Artikel Jurnal

    T-cell receptors identified by a personalized antigen-agnostic screening approach target shared neoantigen KRAS Q61H

    Volker Lennerz; Christoph Doppler; Martina Fatho dkk.

    Frontiers in Immunology, Vol. 16 · 2025 · Inggris · DOAJ Scopus

    Adoptive cell therapy (ACT) with TCR-engineered T-cells represents a promising alternative to TIL- or CAR-T therapies for patients with advanced solid cancers. Currently, selection of therapeutic TCRs critically depends on knowing the target antigens, a condition excluding most patients from…